Light system for plant cultivation
    291.
    发明授权

    公开(公告)号:US10225899B2

    公开(公告)日:2019-03-05

    申请号:US15565768

    申请日:2016-03-17

    Abstract: A lighting system for plant cultivation comprises a light source, a light source driving unit that drives the light source, and a control unit that transmits a pulse signal to the light source driving unit. The control unit comprises a first pulse generating unit that generates a first pulse signal (S1) of a predetermined frequency, a second pulse generating unit that generates a second pulse signal (S2) of a frequency different from the predetermined frequency, and a pulse signal selecting unit that selects any one of the first pulse signal (S1) and the second pulse signal (S2) to transmit the selected one to the light source driving unit. The light source driving unit includes a frequency determining unit that determines whether the frequency of the pulse signal received from the control unit is the frequency of the first pulse signal (S1) or the frequency of the second pulse signal (S2), a first driving unit that, when receiving the first pulse signal (S1) from the control unit, converts the first pulse signal (S1) to a constant current, output to drive the light source, and a second driving unit that, when receiving the second pulse signal (S2) from the control unit, outputs a pulse with an original pulse waveform of the second pulse signal (S2) to drive the light source.

    Intraocular lens insertion apparatus

    公开(公告)号:US10195019B2

    公开(公告)日:2019-02-05

    申请号:US15037469

    申请日:2014-11-19

    Inventor: Takashi Sato

    Abstract: An intraocular lens insertion apparatus includes an accommodating member integrally or independently formed on an apparatus body which is inserted into an eyeball, allowing arrangement of the intraocular lens in the apparatus body by accommodating the intraocular lens therein, and having a hole through which a needle of a syringe which supplies a lubricant to the intraocular lens passes. Further, the intraocular lens insertion apparatus includes a guide wall member formed on the accommodating member at a position adjacent to the hole, and being configured to guide the needle of the syringe to the hole.

    Packet data transmission device and packet data transmission method

    公开(公告)号:US10164741B2

    公开(公告)日:2018-12-25

    申请号:US15521930

    申请日:2015-10-21

    Abstract: [Problem]To prevent either of two packet data having the same content from being affected by noise[Solution]A packet data transmission device (not shown) transmits first packet data 1A, . . . and second packet data 1B, . . . having the same content intermittently with an idle time I therebetween. When the length of the first and second packet data 1A, . . . , 1B, . . . is denoted by LP, the length of the idle time I is denoted by LI, the duration of low-frequency noise N is denoted by LN, the time with no low-frequency noise from the occurrence of one low-frequency noise N to the occurrence of the next low-frequency noise N is denoted by LC, the following expressions (1), (2) are satisfied. Consequently, either the first packet data or the second packet data is transmitted to a receiver without being affected by noise. LI>LN  (1) 2×LP+LI

    Perimeter
    298.
    发明授权

    公开(公告)号:US09826897B2

    公开(公告)日:2017-11-28

    申请号:US15118651

    申请日:2015-02-09

    Abstract: In a perimetry to be conducted, designating an inspection region through a region designator, stimuli are presented to regions separated in an up/down direction, an oblique direction and a right/left direction from the inspection region (“the spaced region”) in addition to the designated inspection region. At the result, examinees are not able to predict to which of both regions, the inspection region and the spaced region the stimuli are presented, thereby obtaining correct inspection results that do not receive a prediction of the examinees.

    DYSLIPIDEMIA THERAPEUTIC AGENT
    299.
    发明申请

    公开(公告)号:US20170304274A1

    公开(公告)日:2017-10-26

    申请号:US15513609

    申请日:2015-09-28

    CPC classification number: A61K31/423 A61K31/455 A61K2300/00

    Abstract: This invention provides a combination-drug composition and a combination use of pharmaceuticals for preventing and/or treating dyslipidemic conditions such as hyper-LDL cholesterolemia in mammals, including humans. This invention pertains to a drug composition for preventing and or treating dyslipidemia and the like, the drug composition including the following: (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy] butyric acid, a salt thereof, or a solvate of either; and nicotinic acid and nicotinic-acid amide, collectively referred to as niacin, an ester derivative thereof, a salt thereof, or a solvate of any of these.

Patent Agency Ranking